Combination therapy of imipramine and melatonin: Additive antidepressant effect in mouse forced swimming test

European Journal of Pharmacology

Volumn 591, Issue 1-3, 2008, Pages 159-163

  Ergün, Yusuf ^a   Orhan, Fatma Özlem ^a   Karaaslan, Mehmet Fatih ^a  

^a KAHRAMANMARAS SUTCU IMAM UNIVERSITY   (Turkey)

Author keywords

(Mouse); Depression; Forced swimming; Imipramine; Melatonin

Indexed keywords

IMIPRAMINE; MELATONIN;

ADD ON THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMBINATION CHEMOTHERAPY; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG DOSE ESCALATION; DRUG DOSE INCREASE; DRUG POTENTIATION; FEMALE; FORCED SWIMMING TEST; LOCOMOTION; LOW DRUG DOSE; MOUSE; NONHUMAN; OPTIMAL DRUG DOSE; PORSOLT SWIM TEST; PRIORITY JOURNAL;

ANIMALS; ANTIDEPRESSIVE AGENTS; DEPRESSIVE DISORDER, MAJOR; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; IMIPRAMINE; MELATONIN; MICE; MICE, INBRED BALB C; MOTOR ACTIVITY; SWIMMING;

EID: 48749122826     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2008.06.070     Document Type: Article

References (39)

1. Aley K.O., and Kulkarni S.K. GABA-mediated modification of despair behavior in mice. Naunyn-Schmiedeberg's Arch. Pharmacol. 339 (1989) 306-311
2. Baez M., and Volosin M. Corticosterone influences forced swim induced immobility. Pharmacol. Biochem. Behav. 49 (1994) 729-736
3. Beck-Friis J., von Rosen D., Kjellman B.F., Ljunggren J.G., and Wetterberg L. Melatonin in relation to body measures, sex, age, season and the use of drugs in patients with major affective disorders and healthy subjects. Psychoneuroendocrinology 9 (1984) 261-277
4. Beck-Friis J., Ljunggren J.G., Thoren M., von Rosen D., Kjellman B.F., and Wetterberg L. Melatonin, cortisol and ACTH in patients with major depressive disorder and healthy humans with special reference to the outcome of the dexamethasone suppression test. Psychoneuroendocrinology 10 (1985) 173-186
5. Bourin M., Mocaer E., and Porsolt R. Antidepressant-like activity of S 20098 (agomelatine) in the forced swim test in rodents: involvement of melatonin and serotonin receptors. J. Psychiatry. Neurosci. 29 (2004) 126-133
6. Brotto L.A., Barr A.M., and Gorzalka B.B. Sex differences in forced-swim and open-field behaviours after chronic administration of melatonin. Eur. J. Pharmacol. 402 (2000) 87-93
7. Coloma F.M., and Niles L.P. Melatonin enhancement of [3H]-gamma-amino butyric acid and [3H] muscimol binding in rat brain. Biochem. Pharmacol. 37 (1988) 1271-1274
8. D'haenen H., Bossuyt A., Mertens J., Bossuyt-Piron C., Gijsemans M., and Kaufman L. SPECT imaging of serotonin receptors in depression. Psychiatry Res. Neuroimaging 45 (1992) 227-237
9. Dolberg O.T., Hirschmann S., and Grunhaus L. Melatonin for the Treatment of Sleep Disturbances in Major Depressive Disorder. Am. J. Psychiatry 155 (1998) 1119-1121
10. 2A receptor-mediated neurotransmission: behavioral and biochemical studies in rat. J. Pharmacol. Exp. Ther. 273 (1995) 304-308
11. Ergun Y., Ergun U.G.O., Orhan F.O., and Kucuk E. Co-administration of a nitric oxide synthase inhibitor and melatonin exerts an additive antidepressant-like effect in the mouse forced swim test. Med. Sci. Mon. 12 (2006) BR307-BR312
12. Fink G., Sumner B.E., Rosie R., Grace O., and Quinn J.P. Estrogen control of central neurotransmission: effect on mood, mental state, and memory. Cell. Mol. Neurobiol. 16 (1996) 325-344
13. Gomar M.D., Castillo J.L., del Aguila C.M., and Acuna-Castroviejo D. Intracerebroventricular injection of naloxone blocks melatonin-dependent brain [3H] flunitrazepam binding. Neuroreport 4 (1993) 987-990
14. Gomar M.D., Fernandez B., del Aguila C.M., Castillo J.L., de Dios Luna J., and Acuna-Castroviejo D. Influence of behaviorally active peptides ACTH-10 and ACTH4-10 on the melatonin modulation of 3H-flunitrazepam receptor binding in the rat cerebral cortex. Neuroendocrinology 60 (1994) 252-260
15. Guo W.G., Todd K., Bourin M., Hascoet M., and Kauadio F. Additive effects of glyburide and antidepressants in the forced swimming test: evidence for the involvement of potassium channel blockade. Pharmacol. Biochem. Behav. 54 (1996) 725-730
16. Handa R.J., Burgess L.H., Kerr J.E., and O'Keefe J.A. Gonadal steroid hormone receptors and sex differences in the hypothalamo-pituitary-adrenal axis. Horm. Behav. 28 (1994) 464-476
17. Hariharasubramanian N., Nair N.P., Pilapil C., Isaac I., and Quirion R. Effect of imipramine on the circadian rhythm of plasma melatonin in unipolar depression. Chronobiol. Int. 3 (1986) 65-69
18. Harkin A., Connor T.J., Burns M.P., and Kelly J.P. Nitric oxide synthase inhibitors augment the effects of serotonin re-uptake inhibitors in the forced swim test. Eur. Neuropsychopharmacol. 14 (2004) 274-281
19. Heiberg I.L., Wegener G., and Rosenberg R. Reduction of cGMP and nitric oxide has antidepressant-like effects in the forced swimming test in rats. Behav. Brain. Res. 134 (2002) 479-484
20. Hill M.N., Brotto L.A., Lee T.T.-Y., and Gorzalka B.B. Corticosterone attenuates the antidepressant-like effects elicited by melatonin in the forced swim test in both male and female rats. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 27 (2003) 905-911
21. Lewy A.J., Bauer V.K., Cutler N.L., and Sack R.L. Melatonin treatment of winter depression: a pilot study. Psychiatry Res. 77 (1998) 57-61
22. Lloyd K.G., Morselli P.L., Deportere H., Fourmer V., Zivkovic B., Scatton B., Broekkamp C., Worms P., and Bartholini G. The potential use of GABA agonists in psychiatric disorders: evidence from studies with progabide in animal models and clinical trials. Pharmacol. Biochem. Behav. 18 (1983) 957-966
23. Mantovani M., Michel Bonetti K., Calixto J.B., Santos A.R., and Rodrigues A.L.S. Antidepressant-like effect of melatonin in the tail suspension test in mice: evidence for involvement of N-methyl-d-aspartate receptors and the d-arginine-nitric oxide pathway. Neurosci. Lett. 343 (2003) 1-4
24. Meguro H., Mori H., Araki K., Kushiya E., Kutsuwada T., Yamazaki M., Kumanishi T., Arakawa M., Sakimura K., and Mishina M. Functional characterization of a heteromeric NMDA receptor channel from cloned cDNAs. Nature 357 (1992) 70-74
25. Micale V., Arezzi A., Rampello L., and Drago F. Melatonin affects the immobility time of rats in the forced swim test: the role of serotonin neurotransmission. Eur. Neuropsychopharmacol. 16 (2006) 538-545
26. Overstreet D.H., Pucilowski O., Retton M.C., Delangrange P., and Guardiola-Lemaitre B. Effects of melatonin receptor ligands on swim test immobility. Neuroreport 9 (1998) 249-253
27. Paul I.A., and Skolnick P. Glutamate and depression: clinical and preclinical studies. Ann.N.Y.Acad.Sci. 1003 (2003) 250-272
28. Peroutka S.J., and Snyder S.H. Long-term antidepressant treatment decreases spiroperidol-labeled serotonin receptor binding. Science 210 (1980) 88-90
29. Porsolt R.D., Bertin A., and Jalfre M. Behavioral despair in mice: a primary screening test for antidepressants. Arch. Int. Pharmacodyn. Ther. 229 (1977) 327-336
30. Raghavendra V., Kaur G., and Kulkarni S.K. Anti-depressant action of melatonin in chronic forced swimming-induced behavioral despair in mice, role of peripheral benzodiazepine receptor modulation. Eur. Neuropsychopharmacol. 10 (2000) 473-481
31. Redrobe J.P., Pinot P., and Bourin M. The effect of the potassium channel activator, cromakalim, on antidepressant drugs in the forced swimming test in mice. Fundam. Clin. Pharmacol. 10 (1996) 524-528
32. Richelson E., and Pfenning M. Blockade by antidepressants ad related compounds of biogenic amine uptake into rat brain synaptosomes; antidepressants selectively block norepinephrine uptake. Eur. J. Pharmacol. 104 (1984) 277-286
33. Rogoz Z., Skuza G., Maj J., and Danysz W. Synergistic effect of uncompetitive NMDA receptor antagonists and antidepressant drugs in the forced swimming test in rats. Neuropharmacology 42 (2002) 1024-1030
34. Rosenstein R.E., and Cardinali D.P. Melatonin increases in vivo GABA accumulation in rat hypothalamus; cerebellum; cerebral cortex and pineal gland. Brain Res. 398 (1986) 403-406
35. Shaji A.V., and Kulkarni S.K. Central nervous system depressant activities of melatonin in rats and mice. Ind. J. Exp. Biol. 36 (1998) 257-263
36. Southam E., and Garthwaite J. The nitric oxide-cyclic GMP signaling pathway in rat brain. Neuropharmacology 32 (1993) 1267-1277
37. Sumaya I.C., Masana M.I., and Dubocovich M.L. The antidepressant-like effect of the melatonin receptor ligand luzindole in mice during forced swimming requires expression of MT2 but not MT1 melatonin receptors. J. Pineal Res. 39 (2005) 170-177
38. Weil Z.M., Hotchkiss A.K., Gatien M.L., Pieke-Dahl S., and Nelson R.J. Melatonin receptor (MT1) knockout mice display depression-like behaviors and deficits in sensorimotor gating. Brain. Res. Bull. 68 (2006) 425-429
39. Wetterberg L. The relationship between the pineal gland and the pituitary-adrenal axis in health, endocrine and psychiatric conditions. Psychoneuroendocrinology 8 (1983) 75-80